传统中药联合标准三联疗法治疗幽门螺杆菌诱发的慢性非萎缩性胃炎及其作用机制

doi:10.13481/j.1671-587x.20160429

吉林大学学报(医学版) ›› 2016, Vol. 42 ›› Issue (04): 789-792.doi: 10.13481/j.1671-587x.20160429

传统中药联合标准三联疗法治疗幽门螺杆菌诱发的慢性非萎缩性胃炎及其作用机制

宋晨雪¹, 王昱博¹, 刘传贵², 谢静姝¹, 路艳娇¹, 王婷¹, 王国强¹, 王亚伟¹, 王放¹, 郑敬彤¹

1. 吉林大学基础医学院病原生物学系, 吉林长春 130021;
2. 吉林华康药业股份有限公司, 吉林敦化 133700

收稿日期:2015-10-21 发布日期:2016-07-20
通讯作者: 王放,教授,博士研究生导师(Tel:0431-85619185,E-mail:wf@jlu.edu.cn) E-mail:wf@jlu.edu.cn
作者简介:宋晨雪(1990-),女,吉林省四平市人,在读理学硕士,主要从事感染与免疫及中西药抑菌活性方面的研究。
基金资助:
吉林省科技厅医药产业发展引导资金资助课题（20150311012YY）

Treatment of Helicobacter pylori induced chronic atrophic gastritiswith traditional Chinese medicine combined standard triple therapyand its mechanisms

SONG Chenxue¹, WANG Yubo¹, LIU Chuangui², XIE Jingshu¹, LU Yanjiao¹, WANG Ting¹, WANG Guoqiang¹, WANG Yawei¹, WANG Fang¹, ZHENG Jingtong¹

1. Department of Pathogen Biology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China;
2. Jilin Huakang Pharmaceutucal CO., LTD, Dunhua 133700, China

Received:2015-10-21 Published:2016-07-20

摘要/Abstract

摘要：

目的：以传统中药清胃止痛微丸联合标准三联疗法治疗幽门螺杆菌诱发的慢性非萎缩性胃炎，采用高通量PCR芯片技术检测炎症相关基因的差异表达情况，阐明其作用机制。方法：选取10例慢性非萎缩性胃炎并发幽门螺杆菌感染患者为治疗组，以清胃止痛微丸联合三联疗法对患者进行治疗14d；随机选取健康者10人作为健康对照组。分别于治疗前后采集研究对象的外周血，应用QIAGEN人类抗菌应答PCR芯片进行外周血总RNA检测，分析治疗前后84个炎症相关基因的差异表达情况。结果：筛选出20个炎症相关基因差异表达。与健康对照组比较，治疗组患者治疗前差异表达的20个基因表达水平明显上调（Fold-change > 2）；与治疗前比较，治疗后该20个基因表达水平下调，且11个基因接近健康对照组水平（Fold-change < 2）。差异表达基因中包括NLRP3炎性复合体相关基因，其中治疗组患者治疗前CASP1、IL1B、NLRP3和PYCARD基因表达水平与健康对照组比较明显上调（P < 0.05），治疗组患者治疗后CASP1、IL1B、NLRP3和PYCARD基因的表达水平与治疗前比较明显下调（P < 0.05）。结论：清胃止痛微丸联合三联疗法治疗幽门螺旋杆菌诱发的慢性非萎缩性胃炎的机制可能是通过抑制慢性非萎缩性胃炎患者NLRP3炎性复合体相关基因的表达，干扰机体与抗菌应答相关的先天性免疫应答，从而起到治疗作用。

关键词: PCR芯片, 清胃止痛微丸, NLRP3炎性复合体, 组合疗法

Abstract:

Objective: To treat the chronic non-atrophic gastritis patients induced by Helicobacter pylori with Qingweizhitong Weiwan combined with standard triple therapy,and to detect the differential expression of related immflammation genes with PCR array, and to clarify its mechanism. Methods: Ten patients with chronic non-atrophic gastritis complicated with Helicobacter pylori infection were used as treatment group and 10 health people were used as health control group. The patients in treatment group were treated with Qingweizhitong Weiwan combined with standard triple therapy for 14 d. The blood samples of the subjects in treatment group and health control group were collected before and after treatment, and QIAGEN human antibacterial response PCR array was performed to test the total RNA inperipheral blood and to analyze the differential expressions of 84 inflammation-related genes. Results: The differential expressions of 20 inflammation-related genes were found. Compared with health control group, the expression levels of 20 genes in treatment group before treatment were up-regulated (Fold-change>2);after treatment, the expression levels of 20 genes were down-regulated, and 11 of them were similar to the level in health control group (Fold-change < 2). More specifically, part of 20 genes was related to NLRP3 inflammasome. Compared with health control group, the gene expression levels of CASP1, IL1B, NLRP3, and PYCARD in treatment group before treatment were up-regulated (P < 0.05).Compared with before treatment, the expression levels of CASP1, IL1B, NLRP3, and PYCARD in treatment group after treatment were down-regulated (P < 0.05). Conclusion: The mechanism of Qingweizhitong Weiwan combined with standard triple therapy in the treatment of chronic non-atrophic gastritis patients induced by Helicobacter pylori may be related to inhibiting the expressions of NLRP3 inflammasome-related genes and interfering the antimicrobial innate immune response.

Key words: PCR array, Qingweizhitong Weiwan, NLRP3 inflammasome, combination therapy

中图分类号:

R737.3

宋晨雪, 王昱博, 刘传贵, 谢静姝, 路艳娇, 王婷, 王国强, 王亚伟, 王放, 郑敬彤. 传统中药联合标准三联疗法治疗幽门螺杆菌诱发的慢性非萎缩性胃炎及其作用机制[J]. 吉林大学学报(医学版), 2016, 42(04): 789-792.

SONG Chenxue, WANG Yubo, LIU Chuangui, XIE Jingshu, LU Yanjiao, WANG Ting, WANG Guoqiang, WANG Yawei, WANG Fang, ZHENG Jingtong. Treatment of Helicobacter pylori induced chronic atrophic gastritiswith traditional Chinese medicine combined standard triple therapyand its mechanisms[J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 789-792.

参考文献

[1] Krizkova S, Kepinska M, Emri G, et al. Microarray analysis of metallothioneins in human diseases-A review [J]. J Pharmaceut Biomed, 2015, 117(1):8-20.

[2] Barbieux C, Bacharouche J, Soussen C, et al. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells [J]. Nanoscale, 2016, 8(9):5268-5279.

[3] Zhang XX, Chen WW, She B, et al. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase Ⅱ, randomized controlled trial [J]. Trials, 2014, 15(1):1-11.

[4] 郭宇丹.辛开苦降法治疗寒热错杂型非萎缩性胃炎的临床研究[D].北京:北京中医药大学,2014.

[5] 潘军伟,卢俊明.调和肝脾法治疗慢性非萎缩性胃炎45例[J].浙江中医杂志,2015,50(8):578.

[6] 陈余妍.慢性非萎缩性胃炎中医证候与幽门螺杆菌感染相关性的研究[D].北京:北京中医药大学,2013.

[7] Noto JM, Peek RM. Helicobacter pylori: an overview [J]. Methods Mol Biol, 2012, 921:7-10.

[8] Wang F, Meng W, Wang B, et al. Helicobacter pylori-induced gastric inflammation and gastric cancer [J]. Cancer Lett, 2014, 345(2):196-202.

[9] 王丹.标准三联疗法联合清胃止痛微丸治疗幽门螺杆菌相关慢性胃炎的疗效[J].中华消化杂志,2013,33(11):772-775.

[10] 王放.清胃止痛微丸体外抑制幽门螺旋杆菌的实验研究[A].山东省第十次消化病学会议暨第七次消化内镜学术会议论文汇编[C]. 山东:济南,2012.

[11] 刘安楠,孙铁英.炎性体在炎症反应中的调节作用[J].生理学报,2012,64(6): 741-750.

[12] De Nardo D, De Nardo CM, Latz E. New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease [J]. Am J Pathol, 2014, 184(1):42-54.

[13] Chen IY, Ichinohe T. Response of host inflammasomes to viral infection [J]. Trends Microbiol, 2015, 23(1):55-63.

[14] Ermler ME, Traylor Z, Patel K, et al. Rift valley fever virus infection induces activation of the NLRP3 inflammasome [J]. Virology, 2014, 449(449):174-180.

[15] 段云.痘疹样胃炎根除幽门螺杆菌前后100例临床疗效分析[J].中国实用内科杂志,2015,35(增1):152-153.

传统中药联合标准三联疗法治疗幽门螺杆菌诱发的慢性非萎缩性胃炎及其作用机制

Treatment of Helicobacter pylori induced chronic atrophic gastritiswith traditional Chinese medicine combined standard triple therapyand its mechanisms

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	李红霞, 宫海叶, 曾萧, 张素素, 刘伯锋. TGF-β1和PLGF在不同类型妊娠滋养细胞疾病患者病变组织中的表达及其意义[J]. 吉林大学学报(医学版), 2018, 44(05): 1041-1046.
[2]	于洋, 徐路, 刘师兵, 李松岩, 徐冶. 杨梅素通过促进DRP1依赖性线粒体分裂诱导人卵巢癌SKOV3细胞凋亡[J]. 吉林大学学报(医学版), 2018, 44(05): 903-907.
[3]	安乐, 杨建征, 胡春梅, 于琼, 肖晗, 郝书弘, 唐艳. 多囊蛋白1基因对人宫颈癌HeLa细胞的抗凋亡作用[J]. 吉林大学学报(医学版), 2018, 44(04): 776-779.
[4]	梁冰, 刘扬, 宋金萍, 曲丹华, 刘纯岩. 组蛋白去乙酰化酶抑制剂SAHA对卵巢癌SKOV3细胞的化疗增敏作用[J]. 吉林大学学报(医学版), 2018, 44(03): 471-476.
[5]	佟玲玲, 敖禹, 盛敏佳, 刘莉. 罕见巨大阔韧带浆液性囊腺瘤1例报告及文献复习[J]. 吉林大学学报(医学版), 2018, 44(03): 635-638.
[6]	上官梦原, 赵菁, 杨艳荣, 张佳悦, 陈俊宇, 赵淑华. 五味子脂A联合卡铂对人卵巢癌Skov3细胞增殖、迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(02): 292-298.
[7]	李思莹, 谢敏, 洪晓玲, 王海啸, 张松灵. 卵巢囊性成熟性畸胎瘤并发类癌3例报告及文献复习[J]. 吉林大学学报(医学版), 2018, 44(02): 398-400.
[8]	上官梦原, 赵菁, 陈俊宇, 杨艳荣, 张佳悦, 赵淑华. 五味子脂A增强卡铂对人卵巢癌Skov3细胞的促凋亡作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(01): 83-89.
[9]	王春伟, 刘春艳, 董丹, 文继红. 肝下巨大卵巢成熟性囊性畸胎瘤并发对侧卵巢子宫内膜异位囊肿1例报告及文献复习[J]. 吉林大学学报(医学版), 2018, 44(01): 182-185.
[10]	徐丽, 张巍. 樟脑磺哑嗪对人宫颈癌HeLa细胞凋亡的诱导作用及其机制[J]. 吉林大学学报(医学版), 2017, 43(06): 1161-1164.
[11]	王雪, 秦瑞, 王皓莹, 高守阳, 兰彦方, 田秀娟. 乳胞素联合卡铂对卵巢癌SKOV3细胞的增殖抑制作用和促凋亡作用[J]. 吉林大学学报(医学版), 2017, 43(06): 1098-1102.
[12]	文思敏, 于多, 吕欣, 王铁君. 紫杉醇联合顺铂与单药顺铂2种同步放化疗方案对中晚期宫颈癌患者预后的影响及安全性评价[J]. 吉林大学学报(医学版), 2017, 43(05): 1002-1008.
[13]	邓子亮, 王森, 黎鹏, 解奎龙, 李淑贤, 周世雄, 贺晓舟, 陈东, 郭洪胜. 白细胞介素37对宫颈癌HeLa细胞顺铂化疗敏感性的增强作用[J]. 吉林大学学报(医学版), 2017, 43(05): 862-866.
[14]	赫东芸, 王立岩, 盛敏佳. 预防性输卵管切除术对卵巢功能的影响及其对盆腔疾病的预防作用[J]. 吉林大学学报(医学版), 2017, 43(03): 635-639.
[15]	蒋雪园, 朴仙姬, 刘畅, 罗英花, 孙虎男, 韩英浩, 申贵男, 臧延青, 金成浩. 四溴苯三唑对宫颈癌HeLa细胞凋亡的诱导作用及其机制[J]. 吉林大学学报(医学版), 2017, 43(03): 561-565.